A Double‐Blind, Placebo‐Controlled, Trial of Amantadine for the Treatment, of Fatigue in Patients with the, Post‐Polio Syndrome
Authors:
- 1 May 1995
- journal article
- clinical trial
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 753 (1) , 296-302
Abstract
Because amantadine has been shown to reduce fatigue in patients with multiple sclerosis, we performed a double-blind, placebo-controlled study to assess its efficacy in the disabling symptom of post-polio fatigue. Twenty-three patients completed six weeks of therapy. Fatigue was measured by the patients using visual analogue scales (twice per day) and numerical fatigue severity scales (once per week) and by overall impression (at end of therapy). Formal neuropsychological testing and serum drug levels were performed to assess compliance. On all measures, no significant difference was found between treatment and placebo groups. Fifty-four percent of patients given amantadine and 43% given placebo reported a decrease in fatigue; however, the visual analogue scales and fatigue severity scales failed to reflect any improvement. Several patients in the treatment group elected to continue amantadine therapy after the study was completed. Our findings suggest that amantadine is not significantly better than placebo in reducing the sensation of fatigue in post-polio syndrome, and that the measures we employed were insensitive to capture the subjective response experienced by a few patients.Keywords
This publication has 21 references indexed in Scilit:
- Pathogenetic Mechanisms of Post‐Polio Syndrome: Morphological, Electrophysiological, Virological, and Immunological CorrelationsAnnals of the New York Academy of Sciences, 1995
- Correlation of Electrophysiology with Pathology, Pathogenesis, and Anticholinesterase Therapy in Post‐Polio SyndromeaAnnals of the New York Academy of Sciences, 1995
- Neuropsychology of Post‐Polio SyndromeAnnals of the New York Academy of Sciences, 1995
- Validity and reliability of a scale to assess fatiguePsychiatry Research, 1991
- Effects of Long-Term Amantadine Treatment on Clinical Symptoms and EEG of a Patient in a Vegetative StateClinical Neuropharmacology, 1990
- Acyclovir Treatment of the Chronic Fatigue SyndromeNew England Journal of Medicine, 1988
- AMANTADINE RESTORES IMPULSE CONDUCTION ACROSS DEMYELINATED NERVE SEGMENTSClinical and Experimental Pharmacology and Physiology, 1987
- A Long-Term Follow-up Study of Patients with Post-Poliomyelitis Neuromuscular SymptomsNew England Journal of Medicine, 1986
- The validity and reliability of the visual analogue mood scaleJournal of Psychiatric Research, 1975
- Dopamine: Release from the Brain in vivo by AmantadineScience, 1971